These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 6317575)
1. A 3q+ marker chromosome in EBV-carrying nasopharyngeal carcinomas. Mitelman F; Mark-Vendel E; Mineur A; Giovanella B; Klein G Int J Cancer; 1983 Dec; 32(6):651-5. PubMed ID: 6317575 [TBL] [Abstract][Full Text] [Related]
2. Cytogenetic characterization of a nasopharyngeal carcinoma cell line and its subline. Tien HF; Lee FY; Chuang SM; Lin CT Cancer Genet Cytogenet; 1990 Oct; 49(1):31-6. PubMed ID: 2397471 [TBL] [Abstract][Full Text] [Related]
3. Cytogenetics of undifferentiated nasopharyngeal carcinoma xenografts from southern Chinese. Huang DP; Ho JH; Chan WK; Lau WH; Lui M Int J Cancer; 1989 May; 43(5):936-9. PubMed ID: 2714899 [TBL] [Abstract][Full Text] [Related]
4. Cytogenetic and viral studies in nasopharyngeal carcinomas in patients of Indian origin. Kumari P; Augustus M; Naik U; Ravi V; Shenoy AM; Rao CR; Kumar RV Indian J Cancer; 1995 Mar; 32(1):10-4. PubMed ID: 7558105 [TBL] [Abstract][Full Text] [Related]
6. Rearrangements of chromosome arm 3q in poorly differentiated nasopharyngeal carcinoma. Waghray M; Parhar RS; Taibah K; al-Sedairy S Genes Chromosomes Cancer; 1992 Jun; 4(4):326-30. PubMed ID: 1377940 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805 [TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas. Yao KT; Zhang HY; Zhu HC; Wang FX; Li GY; Wen DS; Li YP; Tsai CH; Glaser R Int J Cancer; 1990 Jan; 45(1):83-9. PubMed ID: 2153642 [TBL] [Abstract][Full Text] [Related]
9. Cytogenetic studies in three xenografted nasopharyngeal carcinomas. Bernheim A; Rousselet G; Massaad L; Busson P; Tursz T Cancer Genet Cytogenet; 1993 Mar; 66(1):11-5. PubMed ID: 8467469 [TBL] [Abstract][Full Text] [Related]
10. Cytogenetic observations on the malignant epithelial cells and infiltrating lymphocytes of nasopharyngeal carcinoma. Jarvis JE; Finerty S; Epstein MA; Trumper PA; Ball G; Giovanella BC IARC Sci Publ (1971); 1978; (20):299-307. PubMed ID: 730196 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization. Tsang CM; Zhang G; Seto E; Takada K; Deng W; Yip YL; Man C; Hau PM; Chen H; Cao Y; Lo KW; Middeldorp JM; Cheung AL; Tsao SW Int J Cancer; 2010 Oct; 127(7):1570-83. PubMed ID: 20091869 [TBL] [Abstract][Full Text] [Related]
12. Rearranged Epstein-Barr virus genomes and clonal origin in nasopharyngeal carcinoma. Shimakage M; Chatani M; Ikegami N; Hirai K Jpn J Cancer Res; 1989 Jul; 80(7):612-6. PubMed ID: 2551868 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids. Staczek J; Steplewski Z; Weinmann R; Klein G; Koprowski H J Cell Physiol; 1981 Jun; 107(3):391-8. PubMed ID: 6265479 [TBL] [Abstract][Full Text] [Related]
14. Transforming activity of nasopharyngeal carcinoma DNA detectable in mouse JB6 cells. Colburn NH; Raab-Traub N; Becker D; Cao Y; Winterstein D Int J Cancer; 1989 Dec; 44(6):1012-6. PubMed ID: 2558076 [TBL] [Abstract][Full Text] [Related]
15. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. FĂ„hraeus R; Fu HL; Ernberg I; Finke J; Rowe M; Klein G; Falk K; Nilsson E; Yadav M; Busson P Int J Cancer; 1988 Sep; 42(3):329-38. PubMed ID: 2843473 [TBL] [Abstract][Full Text] [Related]
16. 14q+ marker chromosome in an EBV-genome-negative lymph node without signs of malignancy in a patient with EBV-genome-positive nasopharyngeal carcinoma. Mitelman F; Klein G; Andersson-Anvret M; Forsby N; Johansson B Int J Cancer; 1979 Jan; 23(1):32-6. PubMed ID: 215561 [TBL] [Abstract][Full Text] [Related]
17. Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr-virus-positive nasopharyngeal carcinoma cells. Busson P; Zhang Q; Guillon JM; Gregory CD; Young LS; Clausse B; Lipinski M; Rickinson AB; Tursz T Int J Cancer; 1992 Apr; 50(6):863-7. PubMed ID: 1372880 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP. Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396 [TBL] [Abstract][Full Text] [Related]
19. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Seto E; Ooka T; Middeldorp J; Takada K Cancer Res; 2008 Feb; 68(4):1030-6. PubMed ID: 18281477 [TBL] [Abstract][Full Text] [Related]
20. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Klein G; Giovanella BC; Lindahl T; Fialkow PJ; Singh S; Stehlin JS Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4737-41. PubMed ID: 4373728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]